| Literature DB >> 34830391 |
Joana Angélica Loureiro1, Stéphanie Andrade1, Lies Goderis2, Ruben Gomez-Gutierrez3,4, Claudio Soto3, Rodrigo Morales3,5, Maria Carmo Pereira1.
Abstract
Parkinson's disease (PD) is the second most common neurodegenerative disorder. An important hallmark of PD involves the pathological aggregation of proteins in structures known as Lewy bodies. The major component of these proteinaceous inclusions is alpha (α)-synuclein. In different conditions, α-synuclein can assume conformations rich in either α-helix or β-sheets. The mechanisms of α-synuclein misfolding, aggregation, and fibrillation remain unknown, but it is thought that β-sheet conformation of α-synuclein is responsible for its associated toxic mechanisms. To gain fundamental insights into the process of α-synuclein misfolding and aggregation, the secondary structure of this protein in the presence of charged and non-charged surfactant solutions was characterized. The selected surfactants were (anionic) sodium dodecyl sulphate (SDS), (cationic) cetyltrimethylammonium chloride (CTAC), and (uncharged) octyl β-D-glucopyranoside (OG). The effect of surfactants in α-synuclein misfolding was assessed by ultra-structural analyses, in vitro aggregation assays, and secondary structure analyses. The α-synuclein aggregation in the presence of negatively charged SDS suggests that SDS-monomer complexes stimulate the aggregation process. A reduction in the electrostatic repulsion between N- and C-terminal and in the hydrophobic interactions between the NAC (non-amyloid beta component) region and the C-terminal seems to be important to undergo aggregation. Fourier transform infrared spectroscopy (FTIR) measurements show that β-sheet structures comprise the assembly of the fibrils.Entities:
Keywords: Parkinson’s disease; aggregation mechanisms; protein aggregation; protein secondary structure; α-synuclein
Mesh:
Substances:
Year: 2021 PMID: 34830391 PMCID: PMC8624236 DOI: 10.3390/ijms222212509
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 6.208
Figure 1Primary structure with the amino acid (a.a.) sequence of α-synuclein. Positively and negatively charged amino acids are indicated in green and red, respectively. Hydrophobic amino acids are indicated in blue. The imperfect repeats are underlined.
Numeric overview of the charged and hydrophobic a.a. of α-synuclein.
| Region | N-Terminal | NAC 1 | C-Terminal | α-Synuclein |
|---|---|---|---|---|
| Total number of a.a. | 60 | 35 | 45 | 140 |
| Number of charged a.a. | 18 | 3 | 18 | 39 |
| % Charged | 30.0 | 8.6 | 40.0 | 27.8 |
| Total charge | +4 | −1 | −12 | −9 |
| Number of hydrophobic a.a. | 28 | 20 | 16 | 64 |
| % Hydrophobic a.a. | 46.7 | 57.1 | 35.6 | 45.7 |
1 NAC (non-amyloid beta component).
Structures of the surfactants cetyltrimethylammonium chloride (CTAC), sodium dodecylsulfate (SDS), and octyl β-D-glucopyranoside (OG).
| Surfactant | SDS | CTAC | OG |
|---|---|---|---|
| Charge | Anionic | Cationic | Nonionic |
| Molecular weight (Da) | 288.38 | 320.01 | 292.37 |
| Structure |
|
|
|
| Shape of the micelle | Spherical | Spherical | Cylinder |
| Size of the micelle (nm) | 4.8 | 4.8 | R:1.3 |
| L: 9.6 |
Critical micelle concentration (CMC) values from the surface tension measurements of SDS, CTAC, and OG in the absence or presence of α-synuclein (25 µM) in phosphate buffer (pH 7.4) at 21 °C (n = 3).
| Surfactant | CMC without α-Synuclein (mM) | CMC with α-Synuclein (mM) |
|---|---|---|
| SDS | 1.27 ± 0.04 | 0.42 ± 0.01 |
| CTAC | 0.17 ± 0.03 | 0.12 ± 0.04 |
| OG | 19.9 ± 0.3 | 22.5 ± 0.9 |
Figure 2Aggregation kinetics of α-synuclein (35 µM) in the presence of buffer (control) or surfactant in phosphate buffer (pH 7.4 at 37 °C). (a) 0.01 and 2 mM of SDS; (b) 0.1 mM and 0.001 mM of CTAC; (c) 10 mM and 25 mM of OG. Differences in control curves for panels a–c and b are due to reactions being run in separate plates.
Evaluation of α-synuclein aggregation by the thioflavin T (ThT) assay in solutions of 0.1 mM and 2 mM SDS, 0.05 mM and 1 mM CTAC, and 10 mM and 40 mM OG in phosphate buffer (pH 7.4 at 37 °C). “+” means more aggregation than α-synuclein alone and “-” means less aggregation than α-synuclein alone.
| α-Synuclein in SDS Solutions | α-Synuclein in CTAC Solutions | α-Synuclein in OG Solutions | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Days | 1 | 5 | 9 | 1 | 5 | 9 | 1 | 5 | 9 |
| Above CMC | - | - | - | - | - | - | - | - | - |
| Below CMC | + | + | + | - | + | + | - | - | - |
Figure 3Transmission electron microscopy (TEM) images showing the effect of SDS, CTAC, and OG on α-synuclein aggregation. The α-synuclein concentration was 15 μM. The samples were incubated for 5 days at 37 °C in the presence or absence of surfactants in phosphate buffer, 137 mM NaCl, pH 7.4. The studied surfactant concentrations were below and above the critical micelle concentration (CMC) (CTAC 0.05 mM and 1 mM; SDS 0.1 mM and 2 mM; OG 10 mM and 40 mM) in phosphate buffer (pH 7.4). The scale bars correspond to 200 nm.
Figure 4Fourier transform infrared spectroscopy (FTIR) spectra of α-synuclein (15 µM) in the presence of buffer (control) or surfactant in phosphate buffer (pH 7.4 at 37 °C): CTAC (0.05 and 1.00 mM), SDS (0.10 and 2.00 mM), or OG (10.00 and 40.00 mM). The dashed lines represent the curve-fitted components for secondary structure analysis and the solid lines represent the FTIR spectra.
Figure 5Schematic representation of the possible mechanisms for the interactions between α-synuclein with charged and uncharged surfactants at monomeric and micellar concentrations. The experimental data in this work show a significant induction of α-synuclein aggregation with charged monomers.